1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1: Frequency of typical MR imaging signs of histologically proved type 2 FCD reported in the literature
Urbach et al, 2002⁷ Colombo et al, 2003¹⁵ Widdess-Walsh et al, 2005¹⁴ Besson et al, 2008²⁶ Widjaja et al, 2008²⁸ Kim et al, 2009⁴ Krsek et al, 2009⁶ Lerner et al, 2009³ This Study
Period of study 1996–2000 1996–2000 1990–2002 NA 1991–2005 1995–2005 2002–2005 2000–2007 2000–2011
No. of patients 22 15 48 26 13 28 16 64 71
Negative findings on MRI 0 5 (33%) 10 (21%) 0 2 (15%) 6 (21%) 0 1 29 (41%)
Cortical thickening 18 (81%) 10 (67%) NA NA 8 (61%) NA 8 (50%) 43 (67%) 30 (71%)
Blurring of GWM junction 8 (36%) 13 (87%) NA NA 11 (84%) NA 11 (69%) 47 (73%) 38 (90%)
Cortical signal changes NA 6 (40%) NA NA 2 (15%) NA 10 (62%) 22 (35%) 21 (50%)
Subcortical signal changes 22 (100%) 13 (87%) 27 (56%) NA 11 (84%) NA 14 (87%) 64 (100%) 42 (100%)
Transmantle sign 18 (81%) 3 (20%) NA 5 (19%) 8 (72%) NA 6 (37%) NA 35 (83%)
Sulcal abnormalities NA NA NA NA 3 (23%) NA 11 (69%) NA 22 (52%)
Atrophy NA 3 (20%) NA NA 2 (15%) NA 7 (44%) 11 (17%) 0
Note:—NA indicates not available.